CN1237173C - Hemolytic peptide precursor gene of Asian-African wasp aptoxin, polypeptide coded by it and its preparing process - Google Patents
Hemolytic peptide precursor gene of Asian-African wasp aptoxin, polypeptide coded by it and its preparing process Download PDFInfo
- Publication number
- CN1237173C CN1237173C CN 02110746 CN02110746A CN1237173C CN 1237173 C CN1237173 C CN 1237173C CN 02110746 CN02110746 CN 02110746 CN 02110746 A CN02110746 A CN 02110746A CN 1237173 C CN1237173 C CN 1237173C
- Authority
- CN
- China
- Prior art keywords
- asia
- sequence
- melittin
- africa hornet
- prepromelittin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 238000000034 method Methods 0.000 title claims abstract description 18
- 108090000765 processed proteins & peptides Proteins 0.000 title abstract description 48
- 229920001184 polypeptide Polymers 0.000 title abstract description 42
- 102000004196 processed proteins & peptides Human genes 0.000 title abstract description 40
- 230000008569 process Effects 0.000 title description 3
- 101800001442 Peptide pr Proteins 0.000 title description 2
- 230000002949 hemolytic effect Effects 0.000 title 1
- 241000256856 Vespidae Species 0.000 claims abstract description 92
- VDXZNPDIRNWWCW-JFTDCZMZSA-N melittin Chemical compound NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(N)=O)CC1=CNC2=CC=CC=C12 VDXZNPDIRNWWCW-JFTDCZMZSA-N 0.000 claims abstract description 50
- 239000002773 nucleotide Substances 0.000 claims abstract description 46
- 125000003729 nucleotide group Chemical group 0.000 claims abstract description 46
- 108010036176 Melitten Proteins 0.000 claims abstract description 42
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 27
- 102000004169 proteins and genes Human genes 0.000 claims abstract description 18
- 239000002243 precursor Substances 0.000 claims abstract description 14
- 235000018102 proteins Nutrition 0.000 claims description 17
- 230000014509 gene expression Effects 0.000 claims description 15
- 238000002360 preparation method Methods 0.000 claims description 8
- 230000008859 change Effects 0.000 claims description 5
- 239000013604 expression vector Substances 0.000 claims description 5
- 238000012258 culturing Methods 0.000 claims description 4
- 125000003275 alpha amino acid group Chemical group 0.000 claims 1
- 239000002299 complementary DNA Substances 0.000 abstract description 17
- 108091026890 Coding region Proteins 0.000 abstract description 4
- 230000009471 action Effects 0.000 abstract description 4
- 239000003153 chemical reaction reagent Substances 0.000 abstract description 4
- 230000007246 mechanism Effects 0.000 abstract description 3
- 239000002435 venom Substances 0.000 abstract 6
- 210000001048 venom Anatomy 0.000 abstract 6
- 231100000611 venom Toxicity 0.000 abstract 6
- 239000000969 carrier Substances 0.000 abstract 1
- 229940079593 drug Drugs 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 239000000575 pesticide Substances 0.000 abstract 1
- 230000004952 protein activity Effects 0.000 abstract 1
- 239000003659 bee venom Substances 0.000 description 78
- 108010069903 prepromelittin Proteins 0.000 description 71
- 210000004027 cell Anatomy 0.000 description 31
- 150000001413 amino acids Chemical group 0.000 description 25
- 239000012634 fragment Substances 0.000 description 21
- 235000001014 amino acid Nutrition 0.000 description 18
- 239000000047 product Substances 0.000 description 18
- 108091008146 restriction endonucleases Proteins 0.000 description 17
- 241000256844 Apis mellifera Species 0.000 description 11
- 239000000523 sample Substances 0.000 description 11
- 108091034117 Oligonucleotide Proteins 0.000 description 8
- 108020004707 nucleic acids Proteins 0.000 description 8
- 102000039446 nucleic acids Human genes 0.000 description 8
- 150000007523 nucleic acids Chemical class 0.000 description 8
- 239000013612 plasmid Substances 0.000 description 8
- 108020004414 DNA Proteins 0.000 description 7
- 210000004907 gland Anatomy 0.000 description 7
- 238000005516 engineering process Methods 0.000 description 6
- 238000003780 insertion Methods 0.000 description 6
- 230000037431 insertion Effects 0.000 description 6
- 239000007788 liquid Substances 0.000 description 6
- YBYRMVIVWMBXKQ-UHFFFAOYSA-N phenylmethanesulfonyl fluoride Chemical compound FS(=O)(=O)CC1=CC=CC=C1 YBYRMVIVWMBXKQ-UHFFFAOYSA-N 0.000 description 6
- 241000588724 Escherichia coli Species 0.000 description 5
- 241001465754 Metazoa Species 0.000 description 5
- 238000012408 PCR amplification Methods 0.000 description 5
- 125000000539 amino acid group Chemical group 0.000 description 5
- 238000010276 construction Methods 0.000 description 5
- 230000004927 fusion Effects 0.000 description 5
- 238000011160 research Methods 0.000 description 5
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 4
- 241000894006 Bacteria Species 0.000 description 4
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 4
- 108010076504 Protein Sorting Signals Proteins 0.000 description 4
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 4
- 230000001580 bacterial effect Effects 0.000 description 4
- 210000003527 eukaryotic cell Anatomy 0.000 description 4
- 230000013595 glycosylation Effects 0.000 description 4
- 238000006206 glycosylation reaction Methods 0.000 description 4
- BPHPUYQFMNQIOC-NXRLNHOXSA-N isopropyl beta-D-thiogalactopyranoside Chemical compound CC(C)S[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O BPHPUYQFMNQIOC-NXRLNHOXSA-N 0.000 description 4
- 239000002609 medium Substances 0.000 description 4
- 235000015097 nutrients Nutrition 0.000 description 4
- 231100000614 poison Toxicity 0.000 description 4
- 239000002574 poison Substances 0.000 description 4
- 108091033319 polynucleotide Proteins 0.000 description 4
- 102000040430 polynucleotide Human genes 0.000 description 4
- 239000002157 polynucleotide Substances 0.000 description 4
- 238000010839 reverse transcription Methods 0.000 description 4
- 238000013519 translation Methods 0.000 description 4
- 230000014616 translation Effects 0.000 description 4
- PZEUTLIKVUEDLB-UHFFFAOYSA-N 2-[[[2-[[6-amino-2-[[2-[[6-amino-2-[[2-[[2-[[2-[[2-[[2-[2-[[1-[2-[[2-[[2-[[2-[[2-[[2-[[6-amino-2-[[2-[[2-[2-[[2-[[2-[(2-aminoacetyl)amino]-3-methylpentanoyl]amino]acetyl]amino]propanoylamino]-3-methylbutanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]amino]-3-methylbutanoyl]amino]-4-methylpentanoyl]amino]-3-hydroxybutanoyl]amino]-3-methylbutanoyl]amino]acetyl]amino]-4-methylpentanoyl]pyrrolidine-2-carbonyl]amino]propanoylamino]-4-methylpentanoyl]amino]-3-methylpentanoyl]amino]-3-hydroxypropanoyl]amino]-3-(1H-indol-3-yl)propanoyl]amino]-3-methylpentanoyl]amino]hexanoyl]amino]-5-carbamimidamidopentanoyl]amino]hexanoyl]amino]-3-(carbamoylamino)propanoyl]-(3-amino-3-oxopropyl)carbamoyl]amino]pentanediamide Chemical compound CCC(C)C(NC(=O)CN)C(=O)NCC(=O)NC(C)C(=O)NC(C(C)C)C(=O)NC(CC(C)C)C(=O)NC(CCCCN)C(=O)NC(C(C)C)C(=O)NC(CC(C)C)C(=O)NC(C(C)O)C(=O)NC(C(C)C)C(=O)NCC(=O)NC(CC(C)C)C(=O)N1CCCC1C(=O)NC(C)C(=O)NC(CC(C)C)C(=O)NC(C(C)CC)C(=O)NC(CO)C(=O)NC(Cc1c[nH]c2ccccc12)C(=O)NC(C(C)CC)C(=O)NC(CCCCN)C(=O)NC(CCCNC(N)=N)C(=O)NC(CCCCN)C(=O)NC(CNC(N)=O)C(=O)N(CCC(N)=O)C(=O)NC(CCC(N)=O)C(N)=O PZEUTLIKVUEDLB-UHFFFAOYSA-N 0.000 description 3
- 108020004705 Codon Proteins 0.000 description 3
- 108090000790 Enzymes Proteins 0.000 description 3
- 102000004190 Enzymes Human genes 0.000 description 3
- 241000238631 Hexapoda Species 0.000 description 3
- 108700026244 Open Reading Frames Proteins 0.000 description 3
- 241000276498 Pollachius virens Species 0.000 description 3
- 239000000427 antigen Substances 0.000 description 3
- 102000036639 antigens Human genes 0.000 description 3
- 108091007433 antigens Proteins 0.000 description 3
- 238000006243 chemical reaction Methods 0.000 description 3
- 238000001962 electrophoresis Methods 0.000 description 3
- 230000003053 immunization Effects 0.000 description 3
- 238000002649 immunization Methods 0.000 description 3
- 238000002347 injection Methods 0.000 description 3
- 239000007924 injection Substances 0.000 description 3
- 230000004048 modification Effects 0.000 description 3
- 238000012986 modification Methods 0.000 description 3
- 230000009456 molecular mechanism Effects 0.000 description 3
- 108010009291 promelittin Proteins 0.000 description 3
- 238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- NWXMGUDVXFXRIG-WESIUVDSSA-N (4s,4as,5as,6s,12ar)-4-(dimethylamino)-1,6,10,11,12a-pentahydroxy-6-methyl-3,12-dioxo-4,4a,5,5a-tetrahydrotetracene-2-carboxamide Chemical compound C1=CC=C2[C@](O)(C)[C@H]3C[C@H]4[C@H](N(C)C)C(=O)C(C(N)=O)=C(O)[C@@]4(O)C(=O)C3=C(O)C2=C1O NWXMGUDVXFXRIG-WESIUVDSSA-N 0.000 description 2
- 102000000584 Calmodulin Human genes 0.000 description 2
- 108010041952 Calmodulin Proteins 0.000 description 2
- NTYJJOPFIAHURM-UHFFFAOYSA-N Histamine Chemical compound NCCC1=CN=CN1 NTYJJOPFIAHURM-UHFFFAOYSA-N 0.000 description 2
- 108091028043 Nucleic acid sequence Proteins 0.000 description 2
- 101000702488 Rattus norvegicus High affinity cationic amino acid transporter 1 Proteins 0.000 description 2
- 229920002684 Sepharose Polymers 0.000 description 2
- 239000002671 adjuvant Substances 0.000 description 2
- 239000003242 anti bacterial agent Substances 0.000 description 2
- 230000000692 anti-sense effect Effects 0.000 description 2
- 229940088710 antibiotic agent Drugs 0.000 description 2
- 230000000890 antigenic effect Effects 0.000 description 2
- 230000004071 biological effect Effects 0.000 description 2
- 210000004899 c-terminal region Anatomy 0.000 description 2
- 239000003636 conditioned culture medium Substances 0.000 description 2
- 238000001514 detection method Methods 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 230000029087 digestion Effects 0.000 description 2
- 230000008034 disappearance Effects 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 239000000839 emulsion Substances 0.000 description 2
- 238000001976 enzyme digestion Methods 0.000 description 2
- 239000012467 final product Substances 0.000 description 2
- 230000002068 genetic effect Effects 0.000 description 2
- 235000011187 glycerol Nutrition 0.000 description 2
- 238000009396 hybridization Methods 0.000 description 2
- 210000004408 hybridoma Anatomy 0.000 description 2
- 230000003993 interaction Effects 0.000 description 2
- 230000000968 intestinal effect Effects 0.000 description 2
- 150000002500 ions Chemical class 0.000 description 2
- 239000003550 marker Substances 0.000 description 2
- 230000010534 mechanism of action Effects 0.000 description 2
- 239000012528 membrane Substances 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 239000013600 plasmid vector Substances 0.000 description 2
- 238000012545 processing Methods 0.000 description 2
- 210000001236 prokaryotic cell Anatomy 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- 230000010076 replication Effects 0.000 description 2
- 102220023258 rs387907548 Human genes 0.000 description 2
- 239000011780 sodium chloride Substances 0.000 description 2
- 238000001890 transfection Methods 0.000 description 2
- 239000013598 vector Substances 0.000 description 2
- 238000012795 verification Methods 0.000 description 2
- CUJMXIQZWPZMNQ-XYYGWQPLSA-N 13,14-dihydro-15-oxo-prostaglandin E2 Chemical compound CCCCCC(=O)CC[C@H]1[C@H](O)CC(=O)[C@@H]1C\C=C/CCCC(O)=O CUJMXIQZWPZMNQ-XYYGWQPLSA-N 0.000 description 1
- 101100230376 Acetivibrio thermocellus (strain ATCC 27405 / DSM 1237 / JCM 9322 / NBRC 103400 / NCIMB 10682 / NRRL B-4536 / VPI 7372) celI gene Proteins 0.000 description 1
- 108700042778 Antimicrobial Peptides Proteins 0.000 description 1
- 102000044503 Antimicrobial Peptides Human genes 0.000 description 1
- 244000063299 Bacillus subtilis Species 0.000 description 1
- YDNKGFDKKRUKPY-JHOUSYSJSA-N C16 ceramide Natural products CCCCCCCCCCCCCCCC(=O)N[C@@H](CO)[C@H](O)C=CCCCCCCCCCCCCC YDNKGFDKKRUKPY-JHOUSYSJSA-N 0.000 description 1
- 241000699802 Cricetulus griseus Species 0.000 description 1
- 150000008574 D-amino acids Chemical class 0.000 description 1
- 108010016626 Dipeptides Proteins 0.000 description 1
- 206010018910 Haemolysis Diseases 0.000 description 1
- 102000008394 Immunoglobulin Fragments Human genes 0.000 description 1
- 108010021625 Immunoglobulin Fragments Proteins 0.000 description 1
- 241001529936 Murinae Species 0.000 description 1
- CRJGESKKUOMBCT-VQTJNVASSA-N N-acetylsphinganine Chemical compound CCCCCCCCCCCCCCC[C@@H](O)[C@H](CO)NC(C)=O CRJGESKKUOMBCT-VQTJNVASSA-N 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- BZQFBWGGLXLEPQ-UHFFFAOYSA-N O-phosphoryl-L-serine Natural products OC(=O)C(N)COP(O)(O)=O BZQFBWGGLXLEPQ-UHFFFAOYSA-N 0.000 description 1
- 241000283973 Oryctolagus cuniculus Species 0.000 description 1
- 108091005804 Peptidases Proteins 0.000 description 1
- 239000004365 Protease Substances 0.000 description 1
- 102000007056 Recombinant Fusion Proteins Human genes 0.000 description 1
- 108010008281 Recombinant Fusion Proteins Proteins 0.000 description 1
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- 210000001744 T-lymphocyte Anatomy 0.000 description 1
- 241000255993 Trichoplusia ni Species 0.000 description 1
- 229920004890 Triton X-100 Polymers 0.000 description 1
- 239000013504 Triton X-100 Substances 0.000 description 1
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 241000607479 Yersinia pestis Species 0.000 description 1
- HMNZFMSWFCAGGW-XPWSMXQVSA-N [3-[hydroxy(2-hydroxyethoxy)phosphoryl]oxy-2-[(e)-octadec-9-enoyl]oxypropyl] (e)-octadec-9-enoate Chemical compound CCCCCCCC\C=C\CCCCCCCC(=O)OCC(COP(O)(=O)OCCO)OC(=O)CCCCCCC\C=C\CCCCCCCC HMNZFMSWFCAGGW-XPWSMXQVSA-N 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 238000001042 affinity chromatography Methods 0.000 description 1
- 238000005267 amalgamation Methods 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- QGZKDVFQNNGYKY-UHFFFAOYSA-N ammonia Natural products N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 1
- 230000003321 amplification Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000000840 anti-viral effect Effects 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 102220369446 c.1274G>A Human genes 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 210000004671 cell-free system Anatomy 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 229940106189 ceramide Drugs 0.000 description 1
- ZVEQCJWYRWKARO-UHFFFAOYSA-N ceramide Natural products CCCCCCCCCCCCCCC(O)C(=O)NC(CO)C(O)C=CCCC=C(C)CCCCCCCCC ZVEQCJWYRWKARO-UHFFFAOYSA-N 0.000 description 1
- 230000002490 cerebral effect Effects 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 238000010367 cloning Methods 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 229950006137 dexfosfoserine Drugs 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000004945 emulsification Methods 0.000 description 1
- 238000011067 equilibration Methods 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 210000000630 fibrocyte Anatomy 0.000 description 1
- 238000006170 formylation reaction Methods 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- 238000001502 gel electrophoresis Methods 0.000 description 1
- 239000003292 glue Substances 0.000 description 1
- 230000008588 hemolysis Effects 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- 229960001340 histamine Drugs 0.000 description 1
- 210000003630 histaminocyte Anatomy 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 230000001900 immune effect Effects 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 230000002779 inactivation Effects 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 101150109249 lacI gene Proteins 0.000 description 1
- 238000001638 lipofection Methods 0.000 description 1
- 239000002502 liposome Substances 0.000 description 1
- 230000002934 lysing effect Effects 0.000 description 1
- 210000004962 mammalian cell Anatomy 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 108020004999 messenger RNA Proteins 0.000 description 1
- 108091005601 modified peptides Proteins 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 231100000350 mutagenesis Toxicity 0.000 description 1
- 231100000219 mutagenic Toxicity 0.000 description 1
- 230000003505 mutagenic effect Effects 0.000 description 1
- 230000035772 mutation Effects 0.000 description 1
- VVGIYYKRAMHVLU-UHFFFAOYSA-N newbouldiamide Natural products CCCCCCCCCCCCCCCCCCCC(O)C(O)C(O)C(CO)NC(=O)CCCCCCCCCCCCCCCCC VVGIYYKRAMHVLU-UHFFFAOYSA-N 0.000 description 1
- 238000003199 nucleic acid amplification method Methods 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 210000001672 ovary Anatomy 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- DCWXELXMIBXGTH-QMMMGPOBSA-N phosphonotyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(OP(O)(O)=O)C=C1 DCWXELXMIBXGTH-QMMMGPOBSA-N 0.000 description 1
- 230000026731 phosphorylation Effects 0.000 description 1
- 238000006366 phosphorylation reaction Methods 0.000 description 1
- BZQFBWGGLXLEPQ-REOHCLBHSA-N phosphoserine Chemical compound OC(=O)[C@@H](N)COP(O)(O)=O BZQFBWGGLXLEPQ-REOHCLBHSA-N 0.000 description 1
- USRGIUJOYOXOQJ-GBXIJSLDSA-N phosphothreonine Chemical compound OP(=O)(O)O[C@H](C)[C@H](N)C(O)=O USRGIUJOYOXOQJ-GBXIJSLDSA-N 0.000 description 1
- 238000002264 polyacrylamide gel electrophoresis Methods 0.000 description 1
- 239000003910 polypeptide antibiotic agent Substances 0.000 description 1
- 230000004481 post-translational protein modification Effects 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 238000004321 preservation Methods 0.000 description 1
- 230000004853 protein function Effects 0.000 description 1
- 239000012460 protein solution Substances 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 238000002708 random mutagenesis Methods 0.000 description 1
- 238000010188 recombinant method Methods 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 238000012163 sequencing technique Methods 0.000 description 1
- 238000002741 site-directed mutagenesis Methods 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 239000011550 stock solution Substances 0.000 description 1
- 238000007920 subcutaneous administration Methods 0.000 description 1
- 238000010254 subcutaneous injection Methods 0.000 description 1
- 239000007929 subcutaneous injection Substances 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 230000002194 synthesizing effect Effects 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 230000029812 viral genome replication Effects 0.000 description 1
- 230000003612 virological effect Effects 0.000 description 1
- 210000005253 yeast cell Anatomy 0.000 description 1
Landscapes
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Abstract
The present invention discloses an Asia-Africa hornet venom melittin precursor gene coding sequence, coded polypeptide thereof and a preparing method thereof. The cDNA sequence coded protein is a homolog of Italian hornet venom melittin precursor, and has at least 70% of homology with the nucleotide sequence from nucleotide 1 to 213 sites in SEQ ID No. 5. The sequence codes have polypeptide with a sequence showed in SEQ ID No. 6. Additionally, the present invention also provides a method for preparing carriers and host cells containing the Asia-Africa hornet venom melittin precursor and the 130 to 213 nucleotide sequence of the terminals of melittin precursor genes, antibodies related to the Asia-Africa hornet venom melittin, Asia-Africa hornet venom melittin polypeptide having protein activity and related antibodies. The present invention provides a basis for further researching the molecular action mechanism of Asia-Africa hornet venom melittin and developing biological medicines, diagnostic reagents, biochemical reagents and biological pesticides related to the melittin.
Description
Technical field
The present invention relates to the genetically engineered field, relate in particular to Asia-africa hornet melittin precursor (Prepromelittin) gene and encoded polypeptides and preparation method.
Background technology
Apis mellifera (Apis mellifera) melittin (Melittin) is the ultimate constituent of apis mellifera bee venom; account for 40%～50% (Vol.3.New York:Academic of bee venom; 1971; 535), by sources and biochemical property, it is a kind of active polypeptide; wherein 90% haemolysis peptide exists with unbound state; other 10% then with Melittin N1-formylation form exist (Biochem.Biophys.Res.Commun., 1967,27:275-280).It has very important biologic activity, can cause erythrolysis (Z.Physiol.Chem., 1970,351,884), liposome release mark ion (marker ions) (J.Biol.Chem., 1969,244,3575) and mastocyte discharge histamine (J.Pharmacol, 1965,25,29) or the like.Melittin has two kinds of precursors to exist when synthetic.A kind of is Promelittin, finds at the frog's egg of bee venom or injection queen bee poison gland extract.When synthesizing in frog's egg, Promelittin is stable end product, and in poison gland, it will change Melittin lentamente into; Second kind is called Prepromelittin, and molecular weight ratio Promelittin is big, find on the Melittin mRNA that can only in cell-free system, transcribe (Proc.Natl.Acad.Sct.USA, 1978,75,701-704).
Nineteen eighty-three, Vlasak etc. utilize the total RNA reverse transcription of apis mellifera queen bee poison gland to become cDNA, then the double-stranded cDNA of synthetic is cloned in the pBR322 carrier, the construction cDNA library, filter out to have with probe and insert segmental positive colony greater than 200bp, and then with their subclones in the PUC8 carrier, cut evaluation through enzyme again and therefrom filter out 2 positive colonies, check order to wherein containing the maximum segmental PUM13/4 of insertion, the result shows that this insertion sequence is the nucleotide sequence of Prepromelittin, the mature peptide that this cDNA is coded--melittin precursor protein be 49 amino-acid residues (Eur.J.Biochem., 1983,135:123-126).Prepromelittin albumen comes down to the natural fusion rotein of melittin, and it is synthetic after the dipeptides protease hydrolysis becomes bee venom Melittin in the bee venom cell.
Summary of the invention
One of the object of the invention provides the polynucleotide of a kind of Asia-africa hornet bee venom Prepromelittin, the proteic homologue of this polynucleotide encoding apis mellifera bee venom Prepromelittin.
Two of the object of the invention provides a kind of final product by Asia-africa hornet bee venom Prepromelittin polynucleotide encoding--Asia-africa hornet bee venom Melittin albumen.
The object of the invention also provides this preparation Asia-africa hornet bee venom Prepromelittin nucleotide probe, contain the recombinant vectors of the 130-213 nucleotide sequence of Asia-africa hornet bee venom Prepromelittin Nucleotide and Prepromelittin gene end (being this a part of nucleotide sequence of Melittin), contain the host cell of recombinant vectors, and the method for polypeptide antibody.
In the present invention, a kind of isolated dna molecular is provided, it comprises that coding has the nucleotide sequence of the proteic polypeptide of Asia-africa hornet bee venom Prepromelittin, show at least 70% homology from the nucleotides sequence of Nucleotide 1-213 position among described nucleotide sequence and the SEQ ID No.5, perhaps described nucleotide sequence can be hybridized from the Nucleotide of Nucleotide 1-213 position under the moderate stringent condition with among the SEQ ID No.5, preferably, this polypeptide has the sequence shown in the SEQ ID No.6.More preferably, this sequence has among the SEQ ID No.5 nucleotide sequence from Nucleotide 1-213 position.
The final expression product of a kind of isolating Asia-africa hornet bee venom Prepromelittin--Melittin protein active polypeptide also is provided in the present invention, and it comprises: have polypeptide or its active fragments of SEQ ID No.6 aminoacid sequence, or its reactive derivative.Preferably, this polypeptide is to have SEQ ID No.6 polypeptide of sequence.The present invention also provides a kind of carrier, and it contains above-mentioned isolated DNA; A kind of described carrier transformed host cells.
The present invention also provides a kind of preparation to have the final expression product of Asia-africa hornet bee venom Prepromelittin--the method for the proteic active polypeptide of Melittin, and this method comprises:
(a) coding is had the nucleotide sequence of the proteic polypeptide of Asia-africa hornet bee venom Prepromelittin and 130～213 nucleotide sequences (being this a part of nucleotide sequence of Melittin) that coding has a Prepromelittin gene end and operationally be connected in expression regulation sequence, form the expression vector of Asia-africa hornet bee venom Prepromelittin and Melittin, the nucleotides sequence of described nucleotide sequence and SEQ ID No.5 Nucleotide 1-213 position is shown at least 70% homology;
(b) change the expression vector in the step (a) over to host cell, form the reconstitution cell of Asia-africa hornet bee venom Prepromelittin and Melittin;
(c) be fit to express under the condition of Asia-africa hornet bee venom Prepromelittin and Melittin the reconstitution cell in the culturing step (b);
(d) isolate polypeptide with Asia-africa hornet bee venom Melittin protein-active.
The present invention has found the gene of a kind of Asia-africa hornet bee venom Prepromelittin that encodes, the Prepromelittin of this coded by said gene is the natural fusion rotein of bee venom Melittin, bee venom Melittin then is a kind of biologically active peptides, can be applicable to medically painstaking effort official disease, treatment of diseases such as tumour, can be used as antigen and be used for the bee venom immunological reagent, the preparation of bee venom anaphylodiagnosis reagent, can be used as a kind of natural antimicrobial peptide and be used for phytopathy, the control of insect pest also can be used as a kind of model peptide and is used for membrane interaction mechanism, the research of aspects such as the calmodulin mechanism of action.Asia-africa hornet bee venom Prepromelittin gene can be the molecular mechanisms of action relevant with Melittin in the research Asia-africa hornet bee venom, for development and use Asia-africa hornet bee venom resource provides new foundation.
Embodiment
In a specific embodiments of the present invention, isolating polynucleotide total length of the present invention is 213 Nucleotide, and its detailed sequence is seen SEQ ID No.5, and open reading frame is positioned at 1-213 position Nucleotide.In the present invention, " isolating ", " purifying " or " pure substantially " DNA are meant that this DNA or fragment have been arranged in the sequence of its both sides and have separated under native state; Refer to that also this DNA or fragment with under the native state follow the component of nucleic acid to separate, and separate with the protein of in cell, following it.
In the present invention, refer to encode has the nucleotide sequence of the proteic polypeptide of Asia-africa hornet bee venom Prepromelittin to term " Asia-africa hornet bee venom Prepromelittin albumen (or polypeptide) encoding sequence ", as 1-213 position nucleotide sequence and degenerate sequence thereof among the SEQ IDNo.5.This degenerate sequence is meant the encoder block 1-213 position Nucleotide that is arranged in SEQ ID No.5 sequence, and having one or more codons to be encoded, the degenerate codon of same amino acid replaces the back and the sequence that produces.Because the degeneracy of codon, thus with SEQ ID No.5 in 1-213 position nucleotide sequence homology be low to moderate about 70%.The degenerate sequence described sequence of SEQ ID No.6 of also encoding out.This term also comprises can be under the moderate stringent condition, more preferably under the height stringent condition, with among the SEQ ID No.5 from the nucleotide sequence of the nucleotide sequence hybridization of Nucleotide 1-213 position.This term also comprise with SEQ ID No.5 in from the homology of nucleotide sequence at least 70% of Nucleotide 1-213 position, preferably at least 80%, at least 90% nucleotide sequence more preferably.
This term also comprises encoding to have variant form with the proteic SEQ ID No.6 sequence of Asia-africa hornet bee venom Prepromelittin identical function.These variant forms comprise (but being not limited to): the disappearance of several Nucleotide, insertion and/or replacement, and at 5 ' and/or 3 ' several Nucleotide of end interpolation.
In the present invention, " pure substantially " protein or polypeptide are meant that it accounts at least 20% of the total material of sample, preferably at least 50%, more preferably at least 80%, and at least 90% (by dry weight or weight in wet base) best.Purity can be measured with any suitable method, as measure the purity of polypeptide with post layer folding, PAGE or HPLC method.Substantially pure polypeptide is substantially free of the component of following it under the native state.
In the present invention, term " Asia-africa hornet bee venom Prepromelittin protein polypeptide " refers to have the proteic SEQ ID of Asia-africa hornet bee venom Prepromelittin No.6 polypeptide of sequence.This term also comprises the variant form that has with the SEQ ID No.6 sequence of Asia-africa hornet bee venom Prepromelittin albumen identical function.These variant forms comprise (but being not limited to): several amino acid whose disappearances, insertion and/or replacement, and at C-terminal and/or N-terminal interpolation one or several amino acid.For example, in the art, when replacing, can not change proteinic function usually with the close or similar amino acid of performance.Again such as, add one or several amino acid at C-terminal and/or N-terminal and also can not change proteinic function usually.This term also comprises proteic fragment of Asia-africa hornet bee venom Prepromelittin and derivative.
The variant form of this polypeptide comprises: homologous sequence, allelic variant, natural mutation, the induced mutation body, albumen and the final expression product that utilizes anti-Asia-africa hornet bee venom Prepromelittin--the polypeptide or the albumen of the antiserum(antisera) acquisition of Melittin polypeptide that can be coded under high or low rigorous degree condition with the DNA of Asia-africa hornet bee venom Prepromelittin DNA hybridization.The present invention also provides other polypeptide, as comprises Asia-africa hornet bee venom Prepromelittin polypeptide or its segmental fusion rotein.Except the polypeptide of total length almost, the present invention has also comprised the soluble fragments of Asia-africa hornet bee venom Prepromelittin polypeptide.Usually, this fragment have Asia-africa hornet bee venom Prepromelittin polypeptid coding sequence at least about 10 continuous amino acids, usually at least about 30 continuous amino acids,, be 70 continuous amino acids best preferably at least about 50 continuous amino acids.
Invention also provides the analogue of Asia-africa hornet bee venom Prepromelittin albumen or polypeptide, the difference of these analogues and natural Asia-africa hornet bee venom Prepromelittin polypeptide can be the difference on the aminoacid sequence, also can be the difference that does not influence on the modified forms of sequence, perhaps have both at the same time.These polypeptide comprise natural or the inductive genetic variant.The induce variation body can obtain by various technology, as by radiation or be exposed to mutagenic compound and produce random mutagenesis, also can pass through site-directed mutagenesis method or the biological technology of other known moleculars.Analogue also comprises having the analogue that is different from the amino acid whose residue of natural L (as D-amino acid), and has non-natural analogue that exist or synthetic amino acid (as β, γ amino acid).Should be understood that polypeptide of the present invention is not limited to the above-mentioned representational polypeptide that exemplifies.
(the not changing primary structure usually) form of modification comprises; The chemically derived form such as the acetylize or carboxylated of the polypeptide that body is interior or external.Modification also comprises glycosylation, carries out glycosylation modified and polypeptide that produce in the procedure of processing as those in the synthetic and processing of polypeptide or further.This modification can be carried out glycosylated enzyme (as mammiferous glycosylation or deglycosylating enzyme) and finishes by polypeptide is exposed to.Modified forms also comprises have the phosphorylated amino acid residue sequence of (as Tyrosine O-phosphate, phosphoserine, phosphothreonine).Thereby also comprise the polypeptide that has been improved its anti-proteolysis performance or optimized solubility property by modifying.
The present invention also comprises Asia-africa hornet bee venom Prepromelittin polypeptid coding sequence and segmental antisense sequences thereof, and this antisense sequences can be used for suppressing the expression of Asia-africa hornet bee venom Prepromelittin in the cell.
The present invention also comprises a kind of probe molecule, and this molecule has 8-100 of Asia-africa hornet bee venom Prepromelittin polypeptid coding sequence, preferably 1-50 continuous nucleotide usually.This probe can be used for whether existing in the test sample coding Asia-africa hornet bee venom Prepromelittin nucleic acid molecule.
The present invention also comprises the method that detects Asia-africa hornet bee venom Prepromelittin nucleotide sequence, it comprises with above-mentioned probe and sample and hybridizing, whether detection probes combination has taken place then, preferably, this sample is the product behind the pcr amplification, wherein the pcr amplification primer is corresponding to the encoding sequence of Asia-africa hornet bee venom Prepromelittin polypeptide, and can be positioned at the both sides or the centre of this encoding sequence, and primer length is generally 15-50 Nucleotide.
In the present invention, can select various carrier known in the art for use, as commercially available carrier.
In the present invention, term " host cell " comprises prokaryotic cell prokaryocyte and eukaryotic cell.The example of prokaryotic host cell commonly used comprises intestinal bacteria, Bacillus subtilus etc.Eukaryotic host cell commonly used comprises yeast cell, insect cell and mammalian cell, and preferably, this host cell is an eukaryotic cell, as Tn cell, Chinese hamster ovary celI, COS cell etc.
On the other hand, the present invention also comprises Asia-africa hornet bee venom Prepromelittin or the polypeptide of its fragment coding has specific polyclonal antibody and monoclonal antibody, especially monoclonal antibody.Here, " specificity " is meant that antibody capable is incorporated into Asia-africa hornet bee venom Prepromelittin gene product or fragment.Preferably, refer to that those can combine with Asia-africa hornet bee venom Prepromelittin gene product or fragment but nonrecognition and be incorporated into the antibody of other irrelevant antigen molecule.Among the present invention antibody comprise those can in conjunction with and suppress final expression product--the proteic molecule of Melittin of Asia-africa hornet bee venom Prepromelittin gene, comprise that also those do not influence the final expression product of Asia-africa hornet bee venom Prepromelittin gene--the antibody of Melittin protein function.The present invention also comprise those can with modify or without final expression product--the Melittin bonded antibody of the Asia-africa hornet bee venom Prepromelittin gene of modified forms.
The present invention not only comprises complete mono-clonal or polyclonal antibody, but also comprises having immunocompetent antibody fragment, as Fab ' or (Fab)
2Fragment; Heavy chain of antibody; Light chain of antibody; Genetically engineered strand Fv molecule (people such as Ladner, U.S. Patent No. 4,946,778); Or chimeric antibody, as have the murine antibody binding specificity but still keep antibody from the antibody moiety of Asia-africa hornet.
Antibody of the present invention can be prepared by the known various technology of those skilled in that art, for example, the Asia-africa hornet bee venom Prepromelittin gene product of purifying or its have antigenic fragment, can be applied to animal to induce the generation of polyclonal antibody.Similarly, expressing Asia-africa hornet bee venom Prepromelittin or its has antigenic segmental cell and can be used to immune animal and prepare antibody.Antibody of the present invention also can be monoclonal antibody.This type of monoclonal antibody can utilize hybridoma technology prepare (see people such as Kohler,
Nature256; 495,1975; People such as Kohler,
Eur.J.Immunol, 6:511,1976; People such as Kohler,
Eur.J.Immunol, 6:292,1976; People such as Hammerling, I
N Monoclonal Antibodies and T Cell Hybridomas, Elsevier, N.Y., 1981).Antibody of the present invention comprises the final expression product that can block Asia-africa hornet bee venom Prepromelittin gene--the antibody of Melittin function and the antibody that does not influence Asia-africa hornet bee venom Melittin function.Each antibody-like of the present invention can utilize the fragment or the functional zone of Asia-africa hornet bee venom Prepromelittin gene product, obtains by the routine immunization technology.These fragments or functional zone can utilize recombinant methods or utilize Peptide synthesizer synthetic.Can come immune animal and produce with the gene product of preparation in the prokaryotic cell prokaryocyte (for example E.coli) with the final product unmodified form bonded antibody of Asia-africa hornet bee venom Prepromelittin gene; With posttranslational modification form bonded antibody (as the albumen or the polypeptide of glycosylation or phosphorylation), can come immune animal and obtain with the gene product that produces in the eukaryotic cell (for example yeast or insect cell).
In one embodiment of the invention, the cDNA nucleotide sequence of Asia-africa hornet bee venom Prepromelittin is so to obtain, cDNA with the total RNA reverse transcription of Asia-africa hornet poison gland is a template, with a pair of oligonucleotide is that primer-A:5 '-GCTCGAGATGAAATTCTTAGTCAACGTT-3 ' is that forward is to primer, oligonucleotide B:5 '-GAAGCTTCTAACCCTGTTGCCTCTT-3 ' is a reverse primer, carries out PCR.Obtain the cDNA sequence of SEQ ID No.5 after amplified production checked order.Asia-africa hornet bee venom Melittin is the final albumen of Prepromelittin genetic expression in the Asia-africa hornet poison gland, and Asia-africa hornet bee venom Prepromelittin of the present invention provides the foundation for the molecular mechanisms of action relevant with Melittin in the research Asia-africa hornet bee venom.
Below in conjunction with specific examples, further set forth the present invention.Should be understood that these embodiment only to be used to the present invention is described and be not used in the restriction scope of the invention.
Embodiment 1, clone and the mensuration of the cDNA of Asia-africa hornet bee venom Prepromelittin
1. primer amplification
CDNA with the total RNA reverse transcription of Asia-africa hornet poison gland is a template, with a pair of oligonucleotide is that primer-A:5 '-GCTCGAGATGAAATTCTTAGTCAACGTT-3 ' (SEQ ID No.1) is that forward is to primer, oligonucleotide B:5 '-GAAGCTTCTAACCCTGTTGCCTCTT-3 ' (SEQID No.2) is a reverse primer, carries out PCR.The PCR condition of A/B be 94 ℃ 3 minutes, thereupon with 94 ℃ of 40 second, 54 ℃ of 40 second and 72 ℃ carried out 35 circulations in 1 minute, last 72 ℃ were extended 10 minutes, electrophoresis detection obtains the purpose fragment of about 220bp.
2.PCR the order-checking of product
With above-mentioned pcr amplification product A/B and PGEM
-T carrier (Promega) connects, transformed into escherichia coli JM109, extract plasmid with alkaline process, with BigDye terminator v2.0 (Applied BiosystemIncorporation) sequencing kit extractive plasmid is checked order, with computer software splicing order, obtain the cDNA sequence at last, altogether 213bp, detailed sequence is seen SEQ ID No.5, and wherein open reading frame is positioned at 1-213 position Nucleotide.
Derive the aminoacid sequence of Asia-africa hornet bee venom Prepromelittin according to the cDNA sequence that obtains, totally 70 amino-acid residues, its aminoacid sequence sees SEQ ID No.6 for details.
Embodiment 2, and homology relatively
CDNA sequence and proteins encoded thereof with Asia-africa hornet bee venom Prepromelittin of the present invention, in Non-redundant GenBank+EMBL+DDBJ+PDB database and Non-redundant GenBankCDS translations+PDB+SwissProt+Spupdate+PIR database, carry out nucleic acid and albumen homology retrieval with the Blast program.Found that it and apis mellifera bee venom Prepromelittin have significant homology.With the GENTYX software analysis as can be seen, their proteic homology is 95% (seeing attached list 1).Therefore, can infer that Asia-africa hornet bee venom Prepromelittin albumen of the present invention is the homologue of apis mellifera bee venom Prepromelittin, and have similar function.
Nineteen eighty-three, people's Applied Biotechnology methods such as Vlask, utilize the total RNA reverse transcription of apis mellifera queen bee poison gland to become cDNA, by the construction cDNA library, do the library screening with probe then, obtained the new gene of coding apis mellifera bee venom Prepromelittin, the signal peptide of the Prepromelittin that this cDNA is coded and mature peptide are 70 amino-acid residues, 21 amino-acid residues that wherein begin are signal peptide, remaining 49 is mature peptide, comprises the aminoacid sequence (44～70) of terminal M elittin.The aminoacid sequence of Asia-africa hornet bee venom Prepromelittin coded by said gene contains above-described corresponding signal peptide and mature peptide among the present invention, comprises the aminoacid sequence (44～70) of terminal Melittin.Prepromelittin last expression product in Asia-africa hornet is Melittin.And Melittin is present medical science, the very useful active polypeptide of agricultural and biology aspect, it can influence the signal transducting system of cell by multipath, and can induce the synthetic and natural death of cerebral cells of ceramide, have anti-inflammatory, various biological effect such as antibiotic, antiviral; Simultaneously, Melittin has also become a kind of model peptide, is widely used in the research of aspects such as membrane interaction mechanism, the calmodulin mechanism of action.The inventor's Asia-africa hornet Prepromelittin gene is the molecular mechanisms of action relevant with Melittin in the research Asia-africa hornet bee venom, for development and use Asia-africa hornet bee venom resource provides new foundation.
Embodiment 3, the amalgamation and expression of 130～213 nucleotide sequences of Asia-africa hornet bee venom Prepromelittin gene end (being this a part of nucleotide sequence of Melittin) in intestinal bacteria
In this embodiment, with pcr amplification product among the embodiment 1 as inserting fragment.
5 ' the Oligonucleolide primers sequence of using in the PCR reaction is:
5 '-CGTGGATCCGGAATTGGAGCAGTTCTG-3 ' (SEQ ID No.3), this primer contains the restriction enzyme site of BamH I restriction enzyme, is 21 Nucleotide of Asia-africa hornet bee venom coding Melittin sequence after this restriction enzyme site;
3 ' end primer sequence is:
5 '-CGGGAATTCCTAACCCTGTTGCCTCTT-3 ' (SEQ ID No.4), this primer contains the restriction enzyme site of EcoR I restriction enzyme, the partial nucleotide sequence of translation termination and coding Asia-africa hornet bee venom Melittin.
The restriction enzyme site of the restriction enzyme on the primer is corresponding to the restriction enzyme site of the restriction enzyme on the bacterial expression vector pGEX-4T-3, this plasmid vector coding antibiotics resistance (Amp
r), a bacterium replication orgin (Ori), an adjustable promotor/operon of IPTG (P/O), a ribosome bind site (RBS), a gsh marker (GST) and restriction enzyme cloning site.
With BamH I and EcoR I digestion pGEX-4T-3 carrier and insertion fragment, will insert fragment subsequently and be connected to the pGEX-4T-3 carrier and keep open reading frame initial at bacterium RBS.With connecting the E.coli bacterial strain that mixture transforms commodity BL21 by name, BL21 contains the recombinant plasmid of multiple copied subsequently, and it is expressed lac I repressor and carries ammonia benzyl resistance (Amp
r), containing Amp
rThe LB culture dish on screen transformant, the extracting plasmid, in the sequence verification Asia-africa hornet bee venom coding Melittin the cDNA fragment correctly inserted carrier.Adding Amp
rIncubated overnight (O/N) contains the positive transformant clone of required construction in the LB liquid nutrient medium of (100 μ g/ml).(O/N) culture that spends the night dilutes with 1: 10 thinning ratio, is inoculated into then in the large volume LB liquid nutrient medium, and culturing cell grows to 600 optical density(OD) (OD
600) when being 0.4-0.6, add IPTG (" isopropyl-β-D-thiogalactoside ") to final concentration be 1.0mM.By making lacI repressor inactivation, IPTG induces startup P/O to cause gene expression dose to improve.Continue culturing cell after 3-5 hour, centrifugation cell, and with the PBS of 1/20 volume it is suspended; Supersound process lysing cell subsequently; Add Triton X-100 down to final concentration 1% in room temperature (25 ℃) again, mixed gently 30 minutes; Subsequently 10, centrifugal 5 minutes of 000g collects supernatant, the fusion rotein of having expressed with GST Purification Modules purifying again.At last, protein is kept in the stock solution that final concentration is 10% (w/v) glycerine.
SDS-PAGE glue with 15% carries out electrophoresis, identifies that the molecular weight size of expressing protein is about 29.0KDa.
In addition, the amino acid of expressing proteic N end and each 10 amino acid length of C end is checked order, find consistent with the sequence of SEQ ID No.6 with ordinary method.
Embodiment 4, the expression of Asia-africa hornet bee venom Prepromelittin in eukaryotic cell (Tn cell strain, i.e. cabbage looper cell strain)
In this embodiment, with pcr amplification product among the embodiment 1 as inserting fragment.
5 ' the Oligonucleolide primers sequence of using in the PCR reaction is:
5 '-GCTCGAGATGAAATTCTTAGTCAACGTT-3 ' (SEQ ID No.1), this primer contains the restriction enzyme site of Xho I restriction enzyme, is 21 Nucleotide of the Asia-africa hornet bee venom Prepromelittin encoding sequence that begins of signal peptide after this restriction enzyme site;
3 ' end primer sequence is:
5 '-GAAGCTTCTAACCCTGTTGCCTCTT-3 ' (SEQ ID No.2), this primer contains the restriction enzyme site of Hind III restriction enzyme, the part encoding sequence of translation termination and Asia-africa hornet bee venom Prepromelittin.
Restriction enzyme digestion sites is corresponding to the restriction enzyme digestion sites on the Tn fibrocyte expression vector pBacFastHTb on the primer, this plasmid vector coding antibiotics resistance (Amp
rAnd Gm
r), a phage replication starting point (Ori), a virus replication starting point (SV40), T7 promotor, a viral promotors (P-CMV), a SV40 promotor, a SV40 tailing signal and corresponding polyA order, a BGH tailing signal and corresponding polyA order.
With Xho I and Hind III digestion pBacFastHTb carrier and insertion fragment, with linking mixture Transformed E .coli TG I bacterial strain, containing Amp subsequently
rAnd Gm
rThe LB culture dish on screen transformant, add Amp
rAnd Gm
rThe LB liquid nutrient medium in cultivate the clone that (O/N) contains required construction, the extracting plasmid, the cDNA fragment of sequence verification Asia-africa hornet bee venom Prepromelittin has correctly been inserted carrier.Use recombinant plasmid transformed E.coli DH10Bac bacterial strain subsequently, containing Kan
r, Gm
r, tsiklomitsin the LB culture dish on screen transformant, adding Kan
r, Gm
r, tsiklomitsin the LB liquid nutrient medium in cultivate the clone that (O/N) contains required construction, the extracting plasmid through Sepharose 2B column purification, reclaims plasmid-70 ℃ preservation.
Plasmid transfection Tn cell is to adopt lipofection, carries out with Lipofectin (GiBco Life).After the transfection 48 hours, collecting cell and cell conditioned medium, the cell conditioned medium that contains the recombinant virus particle is used for next round to be infected.Cultivate through the TC-100 in 2-3 week continuous passage, collecting cell with ultrasonic degradation method smudge cells, is balance liquid and elutriant with 20mM Tris-CI (PH8.0) solution that contains NaCl0.5mM, imidazola 5mM, PMSF 1mM, the Ni of protein liquid through pre-equilibration
2+Sepharose 6B post is crossed post; Use the solution of the 20mM Tris-CI (PH8.0) that contains imdazola50mM, NaCl 0.5mM, PMSF 1mM again, the flush away foreign protein, the fusion rotein of 6 * His of narrow spectrum absorption, the solution with the 20mM Tris-CI (PH8.0) that contains imdazola 500mM, NaCl 0.5mM, PMSF 1mM carries out wash-out again. and be that dialyzate is dialysed to expressing protein solution with PBS (PH7.4) then.Last freeze-drying is preserved.
With the 16%T that contains 6mol/L urea element (or 24% glycerine), 6%C and 8%T, the 2L-T-SDS-PAGE of 3%C carries out electrophoresis, identifies that the molecular weight size of expressing protein is about 3.0KDa.
In addition, with ordinary method the amino acid of expressing proteic N end and each 10 amino acid length of C end is checked order the albumen of discovery and the white ID No.6 of SEQ, sequence unanimity.
Embodiment 5, preparation antibody
The recombinant protein that obtains in embodiment 3 and 4 is used for immune animal to produce antibody, and concrete grammar is as follows.Recombinant molecule is standby after separating with affinity chromatography.Also available SDS-PAGE gel electrophoresis separates, and electrophoretic band is downcut from gel. also with isopyknic complete Freund ' s adjuvant emulsion.With the albumen of g/ emulsification of 200-300 μ, to the rabbit subcutaneous injection in 12 ages in week.After 21 days,, carry out subcutaneous multiple spot and leg muscle injection with booster immunization with the dosage of 100-200 μ g/ head with the same antigen of non-complete Freund ' s adjuvant emulsion.Carry out one time the intragluteal injection booster immunization after 21 days again.The ability that sero-fast specific reaction activity precipitates Asia-africa hornet bee venom Prepromelittin gene translation product in vivo with it is assessed.
The explanation of SEQ ID No.1 ∽ 6,
The information of SEQ ID NO.1
(i) sequence signature
CA) length: 28 bases
CB) type: nucleic acid
(C) chain: strand
(D) topology; Linear
(ii) molecule-type: oligonucleotide
(vi) sequence description: SEQ ID NO.1
GCTCGAGATGAAATTCTTAGTCAACGTT
The information of SEQ ID NO.2
(i) sequence signature
(A) length: 25 bases
(B) type: nucleic acid
(C) chain: strand
(D) topology: linearity
(ii) molecule-type: oligonucleotide
(vi) sequence description; SEQ ID NO.2
GAAGCTTCTAACCCTGTTGCCTCTT
The information of SEQ ID NO.3:
(i) sequence signature
(A) length: 27 bases
(B) type: nucleic acid
(C) chain: strand
(D) topology: linearity
(ii) molecule-type: oligonucleotide
(vi) sequence description; SEQ ID NO.3
CGTGGATCCGGAATTGGAGCAGTTCTG
The information of SEQ ID NO.4:
(i) sequence signature
(A) length: 27 bases
(B) type: nucleic acid
(C) chain: strand
(D) topology: linearity
(ii) molecule-type: oligonucleotide
(vi) sequence description; SEQ ID NO.4
CGGGAATTCCTAACCCTGTTGCCTCTT
The information of SEQ ID NO.5:
(i) sequence signature
(A) length: 213bp
(B) type: nucleic acid
(C) chain: strand
(D) topology; Linear
(ii) molecule-type: cDNA
(vii) (vi) sequence description: SEQ ID NO.5
1 ATGAAATTCT?TAGTCAACGT?TGCCCTTGTT?TTTATGGTTG?TATACATTTC?TTTCATCTAT
60 GCGGCCCCTG?AACCAGAACC?GGCACCGGAG?GCAGAGGCAG?AGGCAGACGC?GGAGGCAGAT
121 CCGGAAGCAG?GGATTGGAGC?AGTTCTGAAG?GTATTAGCCA?CAGGATTGCC?TGCCCTTATA
181 AGTTGGATTA?AACGTAAGAG?GCAACAGGGT?TAG
The information of SEQ ID NO.6:
(i) sequence signature
(A) length: 70 amino acid
(B) type: amino acid
(C) topological framework; Linear
(ii) molecule-type: polypeptide
(vi) sequence description: SEQ ID NO.6
1 Met?Lys?Phe?Leu?Val?Asn?Val?Ala?Leu?Val?Phe?Met?Val?Val?Tyr?Ile?Ser?Phe?Ile?Tyr
21?Ala?Ala?Pro?Glu?Pro?Glu?Pro?Ala?Pro?Glu?Ala?Glu?Ala?Glu?Ala?Asp?Ala?Glu?Ala?Asp
41?Pro?Glu?Ala?Gly?Ile?Gly?Ala?Val?Leu?Lys?Val?Leu?Ala?Thr?Gly?Leu?Pro?Ala?Leu?Ile
61?Ser?Trp?Ile?Lys?Arg?Lys?Arg?Gln?Gln?Gly
Table I Asia-africa hornet bee venom Prepromelittin and the proteic comparison of apis mellifera bee venom Prepromelittin
Two sequences of carrying out the homology comparison are:
Asia-africa hornet bee venom PhPrepromelittin
Residue sum: 70
Apis mellifera bee venom AmPrepromelittin
Residue sum: 70
The symbol of representing consistent residue is " * "
AmPrepromelittin?1：MKFLVNVALVFMVVYISYIYAAPEPEPAPEPEAEADAEADPEAGIGAVLKVLTTGLPALI
PhPrepromelittin?1：MKFLVNVALVFMVVYISFIYAAPEPEPAPEAEAEADAEADPEAGIGAVLKVLATGLPALI
*****************?************?*********************?*******
AmPrepromelittin?61：SWIKRKRQQG
PhPrepromelittin?61：SWIKRKRQQG
**********
Homology: 95%
Claims (5)
1. an isolated Asia-africa hornet melittin precursor protein encoding sequence is characterized in that its sequence is shown in SEQ ID No.5 nucleotide sequence.
2. an isolating Asia-africa hornet melittin precursor protein is characterized in that it has SEQ IDNo.6 aminoacid sequence.
3. a carrier is characterized in that, it contains the described DNA of claim 1.
4. a host cell is characterized in that, it is with the described carrier transformed host cells of claim 3.
5. preparation method as isolating Asia-africa hornet melittin precursor protein as described in the claim 2 is characterized in that this method comprises:
(a) encoding sequence with claim 1 operationally is connected in expression regulation sequence, forms the expression vector of Asia-africa hornet melittin precursor protein;
(b) change the carrier of expressing in the step (a) over to host cell, form the reconstitution cell of Asia-africa hornet melittin precursor protein;
(c) be fit to express under the condition of Asia-africa hornet melittin precursor protein the reconstitution cell in the culturing step (b);
(d) isolate and have Asia-africa hornet melittin precursor protein.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 02110746 CN1237173C (en) | 2002-02-01 | 2002-02-01 | Hemolytic peptide precursor gene of Asian-African wasp aptoxin, polypeptide coded by it and its preparing process |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 02110746 CN1237173C (en) | 2002-02-01 | 2002-02-01 | Hemolytic peptide precursor gene of Asian-African wasp aptoxin, polypeptide coded by it and its preparing process |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1376794A CN1376794A (en) | 2002-10-30 |
| CN1237173C true CN1237173C (en) | 2006-01-18 |
Family
ID=4741226
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN 02110746 Expired - Fee Related CN1237173C (en) | 2002-02-01 | 2002-02-01 | Hemolytic peptide precursor gene of Asian-African wasp aptoxin, polypeptide coded by it and its preparing process |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1237173C (en) |
-
2002
- 2002-02-01 CN CN 02110746 patent/CN1237173C/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| CN1376794A (en) | 2002-10-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN1128878C (en) | Coding sequence of human methionine sulfoxide reductase, its encoded polypeptide and its preparing process | |
| CN1194089C (en) | Large wasp sedative peptide precursor gene and its coded polypeptide and preparation method | |
| CN1237173C (en) | Hemolytic peptide precursor gene of Asian-African wasp aptoxin, polypeptide coded by it and its preparing process | |
| CN1233830C (en) | China bee and hornet hemolysis peptide precursor gene and coded polypeptide and preparing method | |
| CN1237172C (en) | Asia-africa hornet sedative peptide precursor gene and its coded polypeptide and preparing method | |
| CN1132939C (en) | Coding sequence of pyrophosphate synthetase, its encoded polypeptide and its preparing process | |
| CN1125178C (en) | Coding sequence of human serine/threonine kinase II, its encoded polypeptide and its preparing process | |
| CN1366049A (en) | Chinese bee venom AcHA gene, polypeptide coded by it and its preparing process | |
| CN1277260A (en) | Human actin related protein subunit and its code sequence | |
| CN1125177C (en) | Coding sequence of human short-chain alcohol dehydrogenase, its encoded polypeptide and its preparing process | |
| CN1246529A (en) | Coding sequence of human translation initiation factor subunit, its encoded polypeptide and its preparing process | |
| CN1385526A (en) | Precursor gene of ink chest wasp aptoxin bematolysis peptide, its coded polypeptide and preparation process thereof | |
| CN1249347A (en) | Human calcineurin regulatory subunit, its coding sequence and its preparing process | |
| CN1277259A (en) | Homologous protein of late embryo ample-protein and its code sequence | |
| CN1246532A (en) | Coding sequence of human heat shock associated protein, its encoded polypeptide and its preparing process | |
| CN1259574A (en) | New human phosphatide transferase, its code sequence, prepn. and use thereof | |
| CN1248624A (en) | Novel human capside protein subunit coding sequence, its coded polypeptide and preparation process | |
| CN1376795A (en) | Calmative peptide precursor gene of dark-chest wasp, polypeptide coded by it and its preparing process | |
| CN1291650A (en) | Human hepatome derivative growth factor coding sequence, polypeptide coded with it and its preparing process | |
| CN1249342A (en) | Human phosphatidyl ethanolamine-N-methyltransferase, its coding sequence and its preparing process | |
| CN1249344A (en) | Growth factor genes of human liver cancer cell derivation, its encoded polypeptide and its preparing process | |
| CN1249346A (en) | Human gene sequence, its encoded polypeptide and its preparing process | |
| CN1250097A (en) | New human gene coding series and the polypeptide therewith and its preparation | |
| CN1252448A (en) | Human actin related protein gene and encoded polypeptide and preparation and application | |
| CN1249345A (en) | Human gene coding sequence, its encoded polypeptide and its preparing process |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C19 | Lapse of patent right due to non-payment of the annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |